The Motley Fool

Juno Therapeutics Aktie (NASDAQ:JUNO)

Juno is a clinical-stage cell immunotherapy company focused on revolutionizing medicine by re-engaging the body's immune system to treat cancer.

(0.00)

About

Last updated
Aktueller Kurs
Veränderung (0%)
Schlusskurs
Eröffnung
Geld
Brief
Tagesspanne -
52-Wochen-Spanne -
Volumen 0

Related Articles